Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
11 pending office actions • 8 art units • 10 examiners • 0 of 11 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Mindset Pharma Inc. is currently managing 10 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio of 10 pending actions indicates a steady and active pursuit of patent protection for its pharmaceutical innovations. The company's focus on Biotechnology & Pharmaceuticals is central to its research and development goals, reflecting a commitment to securing rights in the life sciences sector.
The applications are being reviewed by 10 distinct examiners across 8 distinct art units. With 10 pending office actions and 10 distinct examiners, every active case is assigned to a different individual at the patent office. The involvement of 8 distinct art units suggests that the company's technology is broad enough to require review from several different specialized departments, which may lead to a variety of examination perspectives across the 10 total pending office actions.
ABDALHAMEED, MANAHIL MIRGHANI ALI is the busiest examiner for the company, with 1 busiest examiner pending action. Since the total pending office actions number 10 and the busiest examiner pending count is 1, the workload is perfectly distributed among the 10 distinct examiners. This lack of concentration requires the company to manage 10 separate examiner relationships across 8 distinct art units to advance its patent objectives.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (9%) |
| §102 only | 1 (9%) |
| §112 only | 4 (36%) |
| Multi-statute (no §101) | 5 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, ERIC | 2 | 70.8% | +23.3% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.3% | +38.2% |
| MAHLUM, JONATHAN DAVIS | 1 | 51.4% | +25.6% |
| WEDDINGTON, KEVIN E | 1 | 75.2% | +9.8% |
| BELL, SARA ELIZABETH | 1 | 68.8% | +38.2% |
| RONEY, CELESTE A | 1 | 62.8% | +17.5% |
| SHTERENGARTS, SAMANTHA L | 1 | 79.5% | +8.0% |
| AULAKH, CHARANJIT | 1 | 80.6% | -14.5% |
| LEE, CHIHYI NMN | 1 | 33.7% | +60.8% |
| MCDOWELL, BRIAN E | 1 | 74.1% | +30.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18279290 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | AULAKH, CHARANJIT | 5d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | 44d overdue |
| 18265286 | 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | LEE, CHIHYI NMN | 26d overdue |
| 19413522 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | — |
| 18683854 | 3-CYCLOAMINO-INDOLE COMPOUNDS AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MAHLUM, JONATHAN DAVIS | — |
| 18683846 | N-SUBSTITUTED INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | BELL, SARA ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17387883 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | MCDOWELL, BRIAN E | 89d overdue |
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | 44d overdue |
| 18265286 | 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | LEE, CHIHYI NMN | 26d overdue |
| 19568483 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 19413522 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | — |
| 18683854 | 3-CYCLOAMINO-INDOLE COMPOUNDS AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MAHLUM, JONATHAN DAVIS | — |
| 18683846 | N-SUBSTITUTED INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | BELL, SARA ELIZABETH | — |
| 18563898 | HALLUCINOGEN-FATTY ACID COMBINATION | RONEY, CELESTE A | — |
| Art Unit | Apps |
|---|---|
| 1629 | 3 |
| 1625 | 2 |
| 1622 | 1 |
| 1612 | 1 |
| 1623 | 1 |
| 1621 | 1 |
| 1628 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19568483 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Final Rejection | — | Pending | Mar 16, 2026 |
| 19413522 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | 1629 | §102§112 | Non-Final OA | — | Pending | Dec 09, 2025 |
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | 1629 | §102§103§112 | Non-Final OA | 44d overdue | Pending | Apr 25, 2025 |
| 18683854 | 3-CYCLOAMINO-INDOLE COMPOUNDS AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MAHLUM, JONATHAN DAVIS | 1625 | §102§103§112Other | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18683842 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | WEDDINGTON, KEVIN E | 1629 | §112Other | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18683846 | N-SUBSTITUTED INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | BELL, SARA ELIZABETH | 1625 | §102§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18563898 | HALLUCINOGEN-FATTY ACID COMBINATION | RONEY, CELESTE A | 1612 | §112 | Non-Final OA | — | Pending | Nov 23, 2023 |
| 18279293 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | SHTERENGARTS, SAMANTHA L | 1623 | §112 | Final Rejection | 48d | Pending | Aug 29, 2023 |
| 18279290 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | AULAKH, CHARANJIT | 1621 | §112 | Final Rejection | 5d | Pending | Aug 29, 2023 |
| 18265286 | 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | LEE, CHIHYI NMN | 1628 | §103§112 | Final Rejection | 26d overdue | Pending | Jun 05, 2023 |
| 17387883 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | MCDOWELL, BRIAN E | 1624 | §102 | Final Rejection | 89d overdue | Pending | Jul 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial